FAP and neoplasm: Studies have shown that targeting CAR-T cells to fibroblast activation protein (FAP) can remove stromal cells, and engineering CAR-T cells secreting Heparinase enzyme (HPSE) can degrade the tumor matrix thereby overcoming tissue barriers [127–129].